Timothy Rolph - Chief Scientific Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
AKRO on Nasdaq
All Insider Reports
All Insider Reports

Timothy Rolph - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Timothy Rolph for Akero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 129K $6.97M $53.84 Nov 17, 2025 Direct
Stock Option (Right to Buy) 49.9K Oct 7, 2025 Direct Common Stock

Transactions reported by Timothy Rolph for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.